L&K BioMed Showcases "Pectus" at Japanese Conference

Spinal implant manufacturer L&K BioMed announced on the 21st that it participated in the 68th Annual Meeting of the Japanese Society of Plastic and Reconstructive Surgery (JSPRS), held in Tokyo, Japan from April 16 to April 18, together with its local distributor, to showcase its "Pectus" product.

The Japanese Society of Plastic and Reconstructive Surgery was established in 1958 as a society where experts from various fields such as surgery, dermatology, orthopedics, and otolaryngology gather to exchange knowledge on new concepts and previously ambiguous treatments and surgeries. The society holds annual academic conferences, and this year marks its 68th meeting.

The Japanese distributor A, which participated jointly, is currently in the process of signing a contract to expand the market share of "Pectus" and to supply the product in Japan. At present, this distributor supplies the largest volume of Pectus in Japan. Once the contract is finalized, L&K BioMed plans to begin preparations for regulatory approval to sell Pectus.

While the Pectus implant requires regulatory approval, which takes time, the Pectus instrument can be sold shortly after notifying the government. The company plans to prioritize the sale in Japan of the "Crane," a device used to lift the sternum of patients with pectus excavatum before chest wall deformity surgery.

L&K BioMed promoted its self-developed "Pectus" product through meetings with medical professionals and officials attending the conference, and explained its key features through demonstration sessions. A representative from L&K BioMed stated, "It was an opportunity to receive direct feedback on the product at the site," and added, "We will further upgrade the product by incorporating expert opinions."

L&K BioMed also plans to participate in the Chest Wall International Group (CWIG) conference to be held in Nagano, Japan in September, where it will showcase its "Pectus" product.

This content was produced with the assistance of AI translation services.